Fleischhacker WW - Search Results

1

Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.

Fleischhacker WW, Siu CO, Bodén R, Pappadopulos E, Karayal ON, Kahn RS; EUFEST study group. Fleischhacker WW, et al. Int J Neuropsychopharmacol. 2013 Jun;16(5):987-95. doi: 10.1017/S1461145712001241. Epub 2012 Dec 20. Int J Neuropsychopharmacol. 2013. PMID: 23253821 Free article.

2

The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.

Weiss EM, Bilder RM, Fleischhacker WW. Weiss EM, et al. Among authors: fleischhacker ww. Psychopharmacology (Berl). 2002 Jun;162(1):11-7. doi: 10.1007/s00213-002-1053-y. Epub 2002 Apr 17. Psychopharmacology (Berl). 2002. PMID: 12107611 Review.

3

The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.

Hofer A, Hummer M, Kemmler G, Kurz M, Kurzthaler I, Fleischhacker WW. Hofer A, et al. Among authors: fleischhacker ww. Int J Neuropsychopharmacol. 2003 Sep;6(3):201-6. doi: 10.1017/S1461145703003456. Int J Neuropsychopharmacol. 2003. PMID: 12974985 Free article.

4

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, Martin S, Gefvert O. Fleischhacker WW, et al. J Clin Psychiatry. 2003 Oct;64(10):1250-7. doi: 10.4088/jcp.v64n1017. J Clin Psychiatry. 2003. PMID: 14658976 Clinical Trial.

5

Factors influencing compliance in schizophrenia patients.

Fleischhacker WW, Oehl MA, Hummer M. Fleischhacker WW, et al. J Clin Psychiatry. 2003;64 Suppl 16:10-3. J Clin Psychiatry. 2003. PMID: 14680413

6

Osteoporosis in patients with schizophrenia.

Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Moncayo Naveda RC, Rettenbacher MA, Fleischhacker WW. Hummer M, et al. Among authors: fleischhacker ww. Am J Psychiatry. 2005 Jan;162(1):162-7. doi: 10.1176/appi.ajp.162.1.162. Am J Psychiatry. 2005. PMID: 15625215

7

Switching between second-generation antipsychotics: why and how?

Edlinger M, Baumgartner S, Eltanaihi-Furtmüller N, Hummer M, Fleischhacker WW. Edlinger M, et al. Among authors: fleischhacker ww. CNS Drugs. 2005;19(1):27-42. doi: 10.2165/00023210-200519010-00003. CNS Drugs. 2005. PMID: 15651903 Review.

8

Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism.

eder-Ischia U, Ebenbichler C, Fleischhacker WW. eder-Ischia U, et al. Among authors: fleischhacker ww. Essent Psychopharmacol. 2005;6(2):112-7. Essent Psychopharmacol. 2005. PMID: 15765795 Review.

9

QTc variability in schizophrenia patients treated with antipsychotics and healthy controls.

Rettenbacher MA, Eder-Ischia U, Bader A, Edlinger M, Hofer A, Hummer M, Kemmler G, Weiss EM, Hochleitner M, Fleischhacker WW. Rettenbacher MA, et al. Among authors: fleischhacker ww. J Clin Psychopharmacol. 2005 Jun;25(3):206-10. doi: 10.1097/01.jcp.0000162799.64378.fc. J Clin Psychopharmacol. 2005. PMID: 15876897

10

The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial.

Fleischhacker WW, Keet IP, Kahn RS; EUFEST Steering Committee. Fleischhacker WW, et al. Schizophr Res. 2005 Oct 15;78(2-3):147-56. doi: 10.1016/j.schres.2005.06.004. Schizophr Res. 2005. PMID: 16055308 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters